Duke University Health System, Division of Cell Therapy, Heme Malignancies Program

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Hemoglobinuria, Paroxysmal

Studies at this site

• Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients — Completed